Maria Grazia Valsecchi

Author PubWeight™ 122.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med 2009 8.20
2 Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. Science 2013 5.64
3 Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study. Blood 2010 4.17
4 A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial. Lancet 2007 3.94
5 Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. J Natl Cancer Inst 2011 3.51
6 Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. Lancet Oncol 2012 2.29
7 Asociación de Hemato-Oncología Pediátrica de Centro América (AHOPCA): a model for sustainable development in pediatric oncology. Pediatr Blood Cancer 2013 2.23
8 Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study. Blood 2011 2.18
9 Adiponectin and hypertension in normal-weight and obese children. Am J Hypertens 2012 2.09
10 IKZF1 status as a prognostic feature in BCR-ABL1-positive childhood ALL. Blood 2013 1.91
11 Risk of relapse of childhood acute lymphoblastic leukemia is predicted by flow cytometric measurement of residual disease on day 15 bone marrow. J Clin Oncol 2009 1.86
12 Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation 2004 1.82
13 Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial. Lancet 2007 1.68
14 PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity. Hum Mol Genet 2012 1.66
15 Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan. Acta Paediatr 2005 1.63
16 Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clin Sci (Lond) 2007 1.63
17 Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia treated between 1995 and 2005. J Clin Oncol 2010 1.62
18 Long-term results of a randomized trial on extended use of high dose L-asparaginase for standard risk childhood acute lymphoblastic leukemia. J Clin Oncol 2005 1.58
19 Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol. Pediatr Blood Cancer 2010 1.54
20 Nutritional status of children during treatment for acute lymphoblastic leukemia in Guatemala. Pediatr Blood Cancer 2012 1.51
21 Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients. Am J Kidney Dis 2008 1.46
22 [A set of indicators to monitor the adherence to the guidelines for the diagnosis and treatment of breast cancer]. Epidemiol Prev 2014 1.44
23 Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome. Am J Obstet Gynecol 2009 1.42
24 Treatment reduction in highly selected standard-risk childhood acute lymphoblastic leukemia. The AIEOP ALL-9501 study. Haematologica 2005 1.40
25 Modulation of hepcidin production during hypoxia-induced erythropoiesis in humans in vivo: data from the HIGHCARE project. Blood 2010 1.37
26 Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: comparison by genetic randomisation in an international prospective study. Lancet 2005 1.37
27 Improving outcomes for children with cancer in low-income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)-Part I. Pediatr Blood Cancer 2007 1.22
28 Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of infants with mixed-lineage-leukemia (MLL)-rearranged acute lymphoblastic leukemia: results from the Interfant-99 Study. Blood 2010 1.18
29 What is the relevance of Ikaros gene deletions as a prognostic marker in pediatric Philadelphia-negative B-cell precursor acute lymphoblastic leukemia? Haematologica 2013 1.14
30 New policies to address the global burden of childhood cancers. Lancet Oncol 2013 1.12
31 Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants. Haematologica 2013 1.11
32 Usefulness of waist circumference for the identification of childhood hypertension. J Hypertens 2008 1.10
33 Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster based chemotherapy. J Clin Oncol 2008 1.09
34 Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics 2013 1.07
35 A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP group. Br J Haematol 2002 1.06
36 Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol 2008 1.05
37 Nutritional status at diagnosis is related to clinical outcomes in children and adolescents with cancer: a perspective from Central America. Eur J Cancer 2011 1.03
38 Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica 2013 1.01
39 Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol. Blood 2009 1.01
40 Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP). Cancer 2008 0.99
41 Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis. PLoS One 2011 0.99
42 Second malignant neoplasms after treatment of childhood acute lymphoblastic leukemia. J Clin Oncol 2013 0.96
43 Marriage and parenthood among childhood cancer survivors: a report from the Italian AIEOP Off-Therapy Registry. Haematologica 2011 0.95
44 Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study. Am J Epidemiol 2010 0.95
45 Ethmoid adenocarcinoma--from craniofacial to endoscopic resections: a single-institution experience over 25 years. Otolaryngol Head Neck Surg 2011 0.94
46 MR diffusion imaging for preoperative staging of myometrial invasion in patients with endometrial cancer: a systematic review and meta-analysis. Eur Radiol 2014 0.94
47 Eligibility for allogeneic transplantation in very high risk childhood acute lymphoblastic leukemia: the impact of the waiting time. Haematologica 2008 0.94
48 Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years. Am J Epidemiol 2002 0.91
49 Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia. Leuk Res 2013 0.90
50 Long term survivors of childhood cancer: cure and care. The Erice statement. Eur J Cancer 2007 0.90
51 Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age. J Hypertens 2012 0.90
52 Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia. Haematologica 2012 0.89
53 High prevalence of hypertension in normal and underweight Indian children. J Hypertens 2011 0.89
54 Outcome of very late relapse in children with acute lymphoblastic leukemia. Haematologica 2004 0.89
55 Performance of binary markers for censored failure time outcome: nonparametric approach based on proportions. Stat Med 2011 0.89
56 Improving recruitment to clinical trials for cancer in childhood. Lancet Oncol 2008 0.88
57 A weighted Kaplan-Meier estimator for matched data with application to the comparison of chemotherapy and bone-marrow transplant in leukaemia. Stat Med 2002 0.88
58 Endometrial cancer: correlation of apparent diffusion coefficient with tumor grade, depth of myometrial invasion, and presence of lymph node metastases. AJR Am J Roentgenol 2011 0.87
59 Survival after relapse in children with solid tumors: a follow-up study from the Italian off-therapy registry. Pediatr Blood Cancer 2006 0.87
60 Risk factors for highly pathogenic H7N1 avian influenza virus infection in poultry during the 1999-2000 epidemic in Italy. Vet J 2008 0.87
61 FLT3 internal tandem duplication in childhood acute myeloid leukaemia: association with hyperleucocytosis in acute promyelocytic leukaemia. Br J Haematol 2003 0.86
62 Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II. Blood 2002 0.86
63 Childhood high-risk acute lymphoblastic leukemia in first remission: results after chemotherapy or transplant from the AIEOP ALL 2000 study. Blood 2014 0.85
64 Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria. Liver Transpl 2010 0.85
65 A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval. Europace 2013 0.84
66 Axillary lymphadenectomy for breast cancer. A randomized controlled trial comparing a bipolar vessel sealing system to the conventional technique. Breast 2012 0.84
67 Childhood acute lymphoblastic leukemia in Nicaragua: long-term results in the context of an international cooperative program. Pediatr Blood Cancer 2013 0.83
68 Iron accumulation in chronic hepatitis C: relation of hepatic iron distribution, HFE genotype, and disease course. Am J Clin Pathol 2005 0.83
69 Enhanced recovery strategies in colorectal surgery: is the compliance with the whole program required to achieve the target? Int J Colorectal Dis 2013 0.83
70 The controversy of varicella vaccination in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010 0.82
71 Impact of IKZF1 deletions on IKZF1 expression and outcome in Philadelphia chromosome negative childhood BCP-ALL. Reply to "incidence and biological significance of IKZF1/Ikaros gene deletions in pediatric Philadelphia chromosome negative and Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia". Haematologica 2013 0.82
72 Hypertension, prehypertension, and transient elevated blood pressure in children: association with weight excess and waist circumference. Am J Hypertens 2010 0.82
73 The nephrologist's anticoagulation treatment patterns/regimens in chronic hemodialysis patients with atrial fibrillation. J Nephrol 2014 0.81
74 Oxidative stress biomarkers and chromogranin A in uremic patients: effects of dialytic treatment. Clin Biochem 2010 0.81
75 Short-term respiratory outcomes in late preterm infants. Ital J Pediatr 2014 0.81
76 Glutathione S-transferase homozygous deletions and relapse in childhood acute lymphoblastic leukemia: a novel study design in a large Italian AIEOP cohort. Pharmacogenomics 2012 0.80
77 Multivariate permutation test to compare survival curves for matched data. BMC Med Res Methodol 2013 0.80
78 Prospective molecular monitoring of BCR/ABL transcript in children with Ph+ acute lymphoblastic leukaemia unravels differences in treatment response. Br J Haematol 2002 0.80
79 Myometrial invasion in endometrial cancer: diagnostic performance of diffusion-weighted MR imaging at 1.5-T. Eur Radiol 2009 0.80
80 Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies. Haematologica 2006 0.79
81 The thirteenth international childhood acute lymphoblastic leukemia workshop report: La Jolla, CA, USA, December 7-9, 2011. Pediatr Blood Cancer 2012 0.79
82 Effects of exercise training on heart rate and QT interval in healthy young individuals: are there gender differences? Europace 2007 0.79
83 Risk of repeated febrile episodes during chemotherapy-induced granulocytopenia in children with cancer: a prospective single center study. J Chemother 2012 0.78
84 Perfusion computed tomographic assessment of early hepatocellular carcinoma in cirrhotic liver disease: initial observations. J Comput Assist Tomogr 2009 0.78
85 Pharmacokinetics of high-dose methotrexate in infants treated for acute lymphoblastic leukemia. Pediatr Blood Cancer 2009 0.78
86 Defining the correct role of minimal residual disease tests in the management of acute lymphoblastic leukaemia. Br J Haematol 2011 0.78
87 Decreased induction morbidity and mortality following modification to induction therapy in infants with acute lymphoblastic leukemia enrolled on AALL0631: a report from the Children's Oncology Group. Pediatr Blood Cancer 2014 0.78
88 ADC maps in the prediction of pelvic lymph nodal metastatic regions in endometrial cancer. Eur Radiol 2012 0.77
89 Challenges for children and adolescents with cancer in Europe: the SIOP-Europe agenda. Pediatr Blood Cancer 2014 0.77
90 Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study. J Peripher Nerv Syst 2014 0.77
91 Genotypes of the glutathione S-transferase superfamily do not correlate with outcome of childhood acute lymphoblastic leukemia. Leukemia 2003 0.77
92 The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children. J Hypertens 2015 0.77
93 Transplantation in childhood very high risk acute lymphoblastic leukemia in first complete remission: where are we now? J Clin Oncol 2007 0.76
94 Efficacy and safety of venous angioplasty of the extracranial veins for multiple sclerosis. Brave dreams study (brain venous drainage exploited against multiple sclerosis): study protocol for a randomized controlled trial. Trials 2012 0.76
95 Feeding tolerance of preterm infants appropriate for gestational age (AGA) as compared to those small for gestational age (SGA). J Matern Fetal Neonatal Med 2013 0.76
96 A unified model for estimating and testing familial aggregation. Stat Med 2013 0.76
97 TNF-α SNP rs1800629 and risk of relapse in childhood acute lymphoblastic leukemia: relation to immunophenotype. Pharmacogenomics 2014 0.75
98 Importance of minimal residual disease testing during the second year of disease: still no answer? J Clin Oncol 2003 0.75
99 Response to "Low serum adiponectin levels and endothelial dysfunction in childhood hypertension". Am J Hypertens 2013 0.75
100 Glutamine-enriched nutrition does not reduce mucosal morbidity or complications after stem-cell transplantation for childhood malignancies: a prospective randomized study. Transplantation 2011 0.75
101 [Methodologic problems in the analysis of competing risks]. Epidemiol Prev 2002 0.75
102 A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients. J Hypertens 2015 0.75
103 Analysis of interval-censored longitudinal data with application to onco-haematology. Stat Med 2005 0.75
104 Evaluation of alternative prognostic stratifications by prediction accuracy measures on individual survival with application to childhood leukaemia. Eur J Cancer 2009 0.75
105 Preoperative Oral Carbohydrate Load Versus Placebo in Major Elective Abdominal Surgery (PROCY): A Randomized, Placebo-controlled, Multicenter, Phase III Trial. Ann Surg 2017 0.75
106 Robust non-parametric one-sample tests for the analysis of recurrent events. Stat Med 2010 0.75